About
Antibody Therapies
Areas of Focus
Categories
Biologics & BiopharmaceuticalAntibodyBoston & New England
Team (21)
Clinical Trials (3)
View allTotal Trials
3
As Lead Sponsor
3
As Collaborator
0
Total Enrollment
298
By Phase
PHASE2: 1PHASE1: 2
By Status
COMPLETED: 2RECRUITING: 1
Clinical Trials Pipeline3 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT06967805Lead Sponsor
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
PHASE2Recruiting
164 participants
Started: May 5, 2025 · Completed: Aug 31, 2027
NCT06535841Lead Sponsor
A First-in-Human Safety Trial of MTX-474
PHASE1Completed
78 participants
Started: Jul 10, 2024 · Completed: Apr 24, 2025
NCT06401213Lead Sponsor
A First-in-Human Safety Trial of MTX-463
PHASE1Completed
56 participants
Started: Apr 15, 2024 · Completed: Nov 15, 2024
Locations (1)
Headquarters
Boston, MA, United States
Map
Loading map...